| Literature DB >> 29568059 |
Arianna Bellazzo1, Giulio Di Minin2, Elena Valentino1,3, Daria Sicari1,3, Denis Torre4, Luigi Marchionni5, Federica Serpi1, Michael B Stadler6, Daniela Taverna7, Gaia Zuccolotto8, Isabella Monia Montagner9, Antonio Rosato8,9, Federica Tonon10, Cristina Zennaro10, Chiara Agostinis11, Roberta Bulla3, Miguel Mano12,13, Giannino Del Sal14,15, Licio Collavin16,17.
Abstract
The tumor suppressor DAB2IP contributes to modulate the network of information established between cancer cells and tumor microenvironment. Epigenetic and post-transcriptional inactivation of this protein is commonly observed in multiple human malignancies, and can potentially favor progression of tumors driven by a variety of genetic mutations. Performing a high-throughput screening of a large collection of human microRNA mimics, we identified miR-149-3p as a negative post-transcriptional modulator of DAB2IP. By efficiently downregulating DAB2IP, this miRNA enhances cancer cell motility and invasiveness, facilitating activation of NF-kB signaling and promoting expression of pro-inflammatory and pro-angiogenic factors. In addition, we found that miR-149-3p secreted by prostate cancer cells induces DAB2IP downregulation in recipient vascular endothelial cells, stimulating their proliferation and motility, thus potentially remodeling the tumor microenvironment. Finally, we found that inhibition of endogenous miR-149-3p restores DAB2IP activity and efficiently reduces tumor growth and dissemination of malignant cells. These observations suggest that miR-149-3p can promote cancer progression via coordinated inhibition of DAB2IP in tumor cells and in stromal cells.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29568059 PMCID: PMC6030048 DOI: 10.1038/s41418-018-0088-5
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828